These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31412617)

  • 1. In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4.
    Andrianov AM; Nikolaev GI; Kornoushenko YV; Xu W; Jiang S; Tuzikov AV
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31412617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
    Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
    J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of deep learning and molecular modeling to identify small drug-like compounds as potential HIV-1 entry inhibitors.
    Andrianov AM; Nikolaev GI; Shuldov NA; Bosko IP; Anischenko AI; Tuzikov AV
    J Biomol Struct Dyn; 2022 Oct; 40(16):7555-7573. PubMed ID: 33855929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01.
    Andrianov AM; Kashyn IA; Tuzikov AV
    J Mol Graph Model; 2015 Sep; 61():262-71. PubMed ID: 26298811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.
    Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK
    Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.
    Courter JR; Madani N; Sodroski J; Schön A; Freire E; Kwong PD; Hendrickson WA; Chaiken IM; LaLonde JM; Smith AB
    Acc Chem Res; 2014 Apr; 47(4):1228-37. PubMed ID: 24502450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based identification and neutralization mechanism of tyrosine sulfate mimetics that inhibit HIV-1 entry.
    Acharya P; Dogo-Isonagie C; LaLonde JM; Lam SN; Leslie GJ; Louder MK; Frye LL; Debnath AK; Greenwood JR; Luongo TS; Martin L; Watts KS; Hoxie JA; Mascola JR; Bewley CA; Kwong PD
    ACS Chem Biol; 2011 Oct; 6(10):1069-77. PubMed ID: 21793507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
    Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.
    Yang QE; Stephen AG; Adelsberger JW; Roberts PE; Zhu W; Currens MJ; Feng Y; Crise BJ; Gorelick RJ; Rein AR; Fisher RJ; Shoemaker RH; Sei S
    J Virol; 2005 May; 79(10):6122-33. PubMed ID: 15857997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Aminothiazolones as anti-HIV agents that act as gp120-CD4 inhibitors.
    Tiberi M; Tintori C; Ceresola ER; Fazi R; Zamperini C; Calandro P; Franchi L; Selvaraj M; Botta L; Sampaolo M; Saita D; Ferrarese R; Clementi M; Canducci F; Botta M
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3043-52. PubMed ID: 24614386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.
    Bashir T; Patgaonkar M; Kumar SC; Pasi A; Reddy KV
    PLoS One; 2015; 10(4):e0124839. PubMed ID: 25915507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally occurring variability in the envelope glycoprotein of HIV-1 and development of cell entry inhibitors.
    Brower ET; Schön A; Freire E
    Biochemistry; 2010 Mar; 49(11):2359-67. PubMed ID: 20166763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
    Hamza A; Zhan CG
    J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.
    Tintori C; Selvaraj M; Badia R; Clotet B; Esté JA; Botta M
    ChemMedChem; 2013 Mar; 8(3):475-83. PubMed ID: 23404750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor.
    Vermeire K; Schols D
    Expert Opin Investig Drugs; 2005 Oct; 14(10):1199-212. PubMed ID: 16185162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor.
    Zhang C; Zhang H; Huang LS; Zhu S; Xu Y; Zhang XQ; Schooley RT; Yang X; Huang Z; An J
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30463393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators.
    Zhang S; Holmes AP; Dick A; Rashad AA; Enríquez Rodríguez L; Canziani GA; Root MJ; Chaiken IM
    Retrovirology; 2021 Oct; 18(1):31. PubMed ID: 34627310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
    Curreli F; Kwon YD; Belov DS; Ramesh RR; Kurkin AV; Altieri A; Kwong PD; Debnath AK
    J Med Chem; 2017 Apr; 60(7):3124-3153. PubMed ID: 28266845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational design, synthesis and evaluation of new sulphonamide derivatives targeting HIV-1 gp120.
    Vangala R; Sivan SK; Peddi SR; Manga V
    J Comput Aided Mol Des; 2020 Jan; 34(1):39-54. PubMed ID: 31792886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.